Mitral Regurgitation - Valvular Heart Disease Guidelines

Valvular Heart Disease

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/362036

Contents of this Issue

Navigation

Page 44 of 59

43 Figure 9. Diagnosis and Treatment of IE Patient at Risk or With Suspected NVE or PVE Blood cultures × 2 TTE/TEE Modified Duke Criteria Definite or probable IE Antibiotic Rx (I) Temporarily discontinue VKA anticoagulation (IIa) Evaluate for need and timing of surgery Pacer/ICD present Valve dysfunction causing HF Resistant organism (S. aureus, fungi) Heart block or abscess Persistent infection Relapsing PVE Large mobile vegetation (native valve) Recurrent emboli and persistent vegetations despite appropriate antibiotc Rx Infection of leads or device pocket NO YES Remove Hardware Early (I) Remove Hardware (IIa) Early Surgery (IIb) Surgery (I) Early Surgery a (I) a Early surgery is defined as during initial hospitalization before completion of a full therapeutic course of antibiotics. Early Surgery (IIa) Resistant organism (S. aureus, fungi) Valve surgery for IE

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Valvular Heart Disease